Most of the top medical technology companies come from the United States. Some are only divisions of larger companies, like global leader Johnson & Johnson Medical Devices & Diagnostics, or General Electric Healthcare. In 2015, Johnson & Johnson made some 25.1 billion U.S. dollars through its medtech division, and thus was the top U.S.-based company.
Although medtech revenues kept increasing over the last years, the financial crisis had a negative impact on the industry. This can be shown by reference to the number of IPOs, which after the crisis was distinctly lower than before it. However, starting with 2013, a strong upward trend is visible throughout the industry's IPO activity.
The strongest businesses within the medtech industry are in vitro diagnostics (IVD), cardiology, diagnostic imaging, and orthopedics. In vitro diagnostics currently generate some 48 billion U.S. dollars globally, but are forecasted to exceed 70 billion dollars by 2022. Swiss-based pharmaceutical company Roche is the global top manufacturer, generating about nine billion U.S. dollars in worldwide IVD revenue in 2015. It is expected that Roche will further increase its share of the global in vitro diagnostics market from 18 percent in 2015 to nearly 19 percent in 2022.